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The resistance of cells to many drugs simultaneously (multidrug
resistance) often involves the expression of membrane trans-
porters (Mdrs); each recognizes and expels a broad spectrum of
chemically unrelated drugs from the cell. The Escherichia coli Mdr
transporter MdfA is able to transport differentially charged sub-
strates in exchange for protons. This includes neutral compounds,
namely chloramphenicol and thiamphenicol, and lipophilic cations
such as tetraphenylphosphonium and ethidium. Here we show
that the chloramphenicol and thiamphenicol transport reactions
are electrogenic, whereas the transport of several monovalent
cationic substrates is electroneutral. Therefore, unlike with posi-
tively charged substrates, the transmembrane electrical potential
(negative inside) constitutes a major part of the driving force for
the transport of electroneutral substrates by MdfA. These results
demonstrate an unprecedented ability of a single secondary trans-
porter to catalyze discrete transport reactions that differ in their
electrogenicity and are governed by different components of the
proton motive force.
Multidrug resistance (Mdr) transporters that expel drugsfrom the cytoplasm or cytoplasmic membrane to the
external medium constitute one of the major causes of Mdr. Mdr
transporters are widely distributed in bacteria, including patho-
genic strains (1–4). The prokaryotic Mdr transporters are able
to extrude a variety of dissimilar lipophilic compounds, many of
which are positively charged under physiological conditions.
However, there are some bacterial Mdr proteins that also
interact with neutral and zwitterionic drugs, and some trans-
porters export lipophilic anionic drugs (5–8).
We investigated the Mdr phenomenon by using Escherichia
coli Mdr transporter MdfA (9) as a model for secondary Mdr
transporters. MdfA is a 410-aa-long membrane protein of which
close homologues have been identified thus far only in the
pathogenic bacteria Salmonella enterica serovar Typhimurium
(90% identity) (10) and Yersinia pestis (73% identity) (11). Cells
expressing MdfA from a multicopy plasmid exhibit Mdr resulting
from active drug extrusion driven by the proton electrochemical
gradient. Previous studies have proposed that MdfA is a drug
proton antiporter (12). As predicted from the hydropathy plot of
the protein and confirmed by gene-fusion studies, the putative 12
transmembrane regions of MdfA have only one charged amino
acid residue, glutamate at position 26, which is embedded in the
membrane, in the middle of putative transmembrane segment 1
(13). As demonstrated by mutational analysis, the amino acid
residue at this position is important for substrate recognition and
binding by MdfA but not for proton translocation (ref. 14 and
J.A., O.L., and E.B., unpublished data). As mentioned, MdfA
recognizes compounds that are not only structurally unrelated
but also dissimilar in charge, and recent work has demonstrated
simultaneous binding of such substrates to the transporter (15).
This property poses an interesting question regarding the elec-
trogenicity of the substrateproton exchange with positively
charged compounds versus electroneutral ones.
In E. coli, secondary transport is driven mostly by energetically
downhill influx of protons. Depending on the protonsubstrate
stoichiometry of the reaction and the charge on the substrate,
exchange of protons with a substrate by antiporters may result in
a net movement of electric charges (electrogenic transport) or no
net movement of charges (electroneutral transport). Electro-
genic transport will be driven by both components ( and pH)
of the proton electrochemical gradient ( H), but when trans-
port is electroneutral, pH should be the primary driving force.
Importantly, whereas  H remains relatively constant at exter-
nal pH values ranging from 5.0 to 8.0, the electrical () and
chemical (pH) components change. Because internal pH is
kept constant at 7.6 as external pH is raised, pH (inside
alkaline) drops and even becomes inverted (inside acid) above
pH 7.6 (16), whereas  (inside negative) increases. Accord-
ingly, pH-driven electroneutral transport processes should be
inhibited at alkaline external pH values, whereas electrogenic
transport processes should be less affected. Of the secondary
transport proteins described to date, they catalyze either elec-
trogenic or electroneutral translocation reactions. In this regard,
Mdr transporters represent a unique subset of secondary trans-
porters. Because of their ability to transport differentially
charged substrates, they are theoretically capable of catalyzing
transport reactions that are electrically distinct. Most probably,
a transport process that involves  H-dependent active extru-
sion of neutral drugs is electrogenic, but the degree to which 
or pH (inside negative and alkaline) contributes to the uptake
or extrusion of a given solute may vary (17).
Here we have examined the intriguing possibility that different
MdfA-mediated transport reactions exist, each accommodating
a distinct group of substrates. The results demonstrate that the
MdfA-catalyzed transport of neutral substrates is indeed elec-
trogenic, whereas transport of cationic substrates is electroneu-
tral. Thus, in addition to their promiscuity regarding substrate
recognition, Mdr transporters are also versatile regarding the
component of  H used for transport.
Materials and Methods
Materials. E. coli lipids were from Avanti. [3H]Tetraphenylphos-
phonium (TPP) [32 Cimmol (1 Ci  37 GBq)] was purchased
from Amersham Pharmacia, and [3H]chloramphenicol (20 Ci
mmol) was purchased from NEN. Nigericin, valinomycin, car-
bonyl cyanide m-chlorophenyl hydrazone (CCCP), ATP,
ethidium bromide (EtBr), chloramphenicol, kanamycin,
Hoechst 33342, DNase, phosphatidyl choline, and ampicillin all
were purchased from Sigma. Benzalkonium chloride was ob-
tained from Calbiochem, and thiamphenicol was obtained from
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ICN. Oxonol V and 9-amino-6-chloro-2-methoxyacridine were
purchased from Molecular Probes. N-dodecyl-maltoside was
purchased from Anatrace (Maumee, OH). His Bind resin was
obtained from Novagen and used for purification of MdfA-6His.
Cellulose acetate and nitrocellulose filters (0.2 m) were from
Schleicher & Schu¨ll. Polycarbonate filters (0.4 m) were from
Osmonics (Minnetonka, MN). All other materials were reagent-
grade and obtained from commercial sources.
Drug-Resistance Assays. E. coli UTmdfA::kan (14) was trans-
formed with the indicated plasmid (pT7-5 or pT7-5 mdfA-6His),
and after 1 h of recovery at 37°C the transformants were diluted
as indicated and plated over LB agar plates. The plates were
supplemented with 75 mM bis-Tris-propane at the desired pH
and ampicillin (100 gml), kanamycin (30 gml), and the
indicated concentrations of the test compounds (chloramphen-
icol, thiamphenicol, benzalkonium, or EtBr). The ability of the
transformants to form single colonies was recorded after 36 h
at 37°C.
Transport Assays in Whole Cells. EtBr-eff lux assays (6) and chlor-
amphenicol or TPP uptake assays (15) were conducted as
described with the following modifications: For EtBr efflux, E.
coli UTL2mdfA::kan cells harboring pT7-5 or pT7-5 mdfA-6His
(15) were grown to an OD600 of 0.8 units in LB broth and kept
on ice. Two-milliliter aliquots (OD600 of 0.3 units) were pelleted
and resuspended in 2 ml of 50 mM potassium phosphate at the
desired pH and supplemented with 100 M CCCP and 5 M
EtBr. Cells were incubated for 5 at 35°C, pelleted, and resus-
pended in the same buffer but without CCCP. Transport was
initiated by the addition of 0.2% glucose. For chloramphenicol
uptake, E. coli UTmdfA::kan cells harboring pT7-5 or pT7-5
mdfA-6His were grown to an OD600 of 0.5 units in LB broth,
washed once in 50 mM potassium phosphate at the desired pH,
resuspended in the same buffer, at an OD420 of 30 units, and
aliquoted (50 l). After 15 min recovery at 35°C in the presence
of 0.2% glucose, transport was initiated by the addition of
an equal volume (50 l) of the same buffer containing [3H]-
chloramphenicol. [3H]TPP uptake was conducted essentially
the same as with chloramphenicol. UTL2mdfA::kan cells were
resuspended to an OD420 of 13.5 units. In experiments with the
ionophores valinomycin (5 M) or nigericin (2 M), the outer-
membrane permeability mutant was made further permeable to
the ionophores by a 15-min incubation at 35°C in the presence
of 2.5 mM EDTA, 1% ethanol, and the test ionophore.
Preparation of inverted Membrane Vesicles. E. coli UTL2mdfA::kan
cells overexpressing MdfA were grown and treated as described
(15). Inverted membrane vesicles were prepared from these cells
as described (18). Cells were washed once in 50 mM potassium
phosphate, pH 7.55 mM MgSO4. Cells (0.2 gml) in 50 mM
potassium phosphate, pH 7.55 mM MgSO430 g/ml DNase
0.5 mM Pefablock10 mM 2-mercaptoethanol were disrupted by
French Press at 8,000 psi (1 psi  6.89 kPa) (three passages).
Vesicles in 50 mM potassium phosphate, pH 7.510% glycerol
were frozen in liquid nitrogen and kept at 80°C.
Hoechst 33342 Transport in Inverted Membrane Vesicles. Transport
of Hoechst 33342 was conducted as described (19) with the
following modifications: 4l of vesicles (30 mg of protein per ml)
were diluted into 2 ml of 50 mM Hepes, pH 7.050 mM
potassium gluconate10 mM magnesium sulfate0.2 M
Hoechst 33342. Transport was initiated by the addition of 0.2
mM ATP. Nigericin and valinomycin (2 M each) were added
as indicated.
Membrane Potential Measurements in Inverted Membrane Vesicles.
Forty microliters of vesicles (30 mg of protein per ml) were
diluted into 2 ml of 50 mM Hepes, pH 7.050 mM potas-
sium gluconate10 mM magnesium sulfate0.5 M oxonol V. A
transmembrane potential was generated by the addition of
0.4 mM ATP. CCCP (10 M) was used to completely abolish
the membrane potential. The fluorescence was measured in a
Perkin–Elmer SL50 fluorimeter with excitation and emission
wavelengths of 599 and 634 nm, respectively, and a slit width
of 10 nm.
Purification and Reconstitution of MdfA. MdfA was purified to near
homogeneity as described (15). For reconstitution, a combina-
tion of methods was used (20–22). Seventy-five milligrams of 3:1
E. coli lipids (acetoneether washed) and egg-yolk phosphatidyl
choline were dissolved in 2 ml of 20 mM sodium phosphate, pH
7.0100 mM sodium gluconate2 mM magnesium sulfate0.3%
glycerol0.03% N-dodecyl-maltoside. Dithiothreitol (1 mM) was
added to the argon-flushed lipids, which then were subjected to
two rounds of freezing (in liquid nitrogen) and thawing (undis-
turbed at room temperature). Next, preformed liposomes were
prepared by extrusion (10 times) through a double layer of
0.4-m polycarbonate filters, and purified MdfA (0.5 ml of 2
mgml protein) was added in 20 mM TrisHCl, pH 7.90.5 M
NaCl250 mM imidazole0.1% N-dodecyl-maltoside1% glyc-
erol0.2 mgml lipids. As a control, 0.5 ml of the same buffer but
without protein was added to identically treated lipids. The
mixture (2.5 ml) was agitated gently at 4°C for 30 min and then
squirted (at room temperature) into vigorously stirred 210 ml of
argon-flushed 20 mM sodium phosphate, pH 7.0100 mM
Na-gluconate2 mM magnesium sulfate. After 20 min of stirring
at room temperature, proteoliposomes were collected by 1 h of
centrifugation at 185,000  g, and resuspended in the same
buffer at a protein concentration of 0.8 mgml. Proteoliposomes
were aliquoted, frozen in liquid nitrogen, and stored at 80°C
for up to 6 months.
Transport Assays in Proteoliposomes. For all experiments, proteo-
liposomes were thawed undisturbed at room temperature and
diluted at least 10-fold with the desired loading buffer. After two
cycles of freezing and thawing, the proteoliposomes were ex-
truded (7–10 times until clear) through a double layer of 0.4-m
polycarbonate filters. After centrifugation (7 min at 280,000 
g), the proteoliposomes were resuspended in the same buffer at
a protein concentration of 8 mgml (for TPP uptake) or 2
mgml (for chloramphenicol uptake). For evaluation of diffu-
sion potential formation, proteoliposomes or liposomes were
routinely assayed by fluorescence spectrometry (Perkin–Elmer
SL50 fluorimeter) by using oxonol V (0.5 M; excitation, 599
nm; emission, 634 nm; slit width, 10 nm) for monitoring  and
9-amino-6-chloro-2-methoxyacridine (1 M; excitation, 409 nm;
emission, 474 nm; slit width, 3 nm) for pH. For generation of
pH (inside acidic), proteoliposomes were loaded with 150 mM
NH4Cl50 mM potassium gluconate5 mM TrisHCl, pH 6.5
[and diluted 100-fold into the same buffer (control, no energy
gradient)], or 150 mM choline chloride50 mM potassium
gluconate5 mM TrisHCl, pH 7.5. For generation of  (inside
positive), proteoliposomes were loaded with 120 mM sodium
gluconate2 mM magnesium sulfate5 mM sodium phosphate,
pH 7.0 [and diluted 100-fold into the same buffer (control, no
energy gradient)], or 120 mM potassium gluconate2 mM
MgSO45 mM potassium phosphate, pH 7.05 M valinomycin.
For the generation of  H (inside positive and acidic), proteo-
liposomes were loaded with 120 mM sodium gluconate2 mM
magnesium sulfate150 mM NH4Cl5 mM TrisHCl, pH 6.5 [and
diluted 100-fold into the same buffer (control, no energy gra-
dient)], or 120 mM potassium gluconate2 mM MgSO4150 mM
choline chloride5 mM TrisHCl, pH 7.5.5 M valinomycin.
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Transport was conducted in 50- (TPP) or 200-l (chloram-
phenicol) samples and terminated by the addition of 1.5 ml of
ice-cold LiCl (0.1 M) and filtration through 0.2-m filters
(nitrocellulose for chloramphenicol or cellulose acetate for
TPP) followed by an additional 1.5-ml wash. Experiments were
repeated three times, each in triplicate.
Results
The MdfA-Mediated Resistance Toward Cationic and Neutral Drugs Is
Affected Differently by Changes in the External pH. Initial evidence
suggesting that the transport reactions of differentially charged
substrates may differ originated from the results of drug-
resistance assays on solid medium. Drug resistance to positively
charged and uncharged compounds was tested under various pH
conditions and over a broad range of drug concentrations. The
results of a representative experiment are shown in Fig. 1. In the
absence of drugs, cells harboring either plasmid, pT7-5 or pT7-5
(mdfA), grew equally well in the pH range of 6.5–8.0. However,
when the positively charged substrates EtBr or benzalkonium
were added to the medium, only cells expressing MdfA were able
to grow, but the growth was attenuated at basic pH. In contrast,
the MdfA-mediated resistance to the neutral drugs chloram-
phenicol and thiamphenicol was maintained also at pH 8.0.
Because no growth of control cells (cells that do not express
MdfA) was observed at the drug concentrations tested (Fig. 1A),
the effect of pH on their intrinsic drug resistance was tested at
extremely low drug concentrations (2–4% of the drug concen-
tration used in Fig. 1A). As shown (Fig. 1B), Mdr of control cells
was also affected by external pH changes. However, unlike
MdfA-expressing cells, control cells are generally less resistant at
basic pH toward both cationic and neutral drugs.
The Transport of Positively Charged Substrates Is Inhibited at a Basic
pH, Whereas the Transport of Chloramphenicol Remains Unaffected.
The dissimilar pH-dependent resistance phenotypes described
above might reflect a pH-dependent transport phenomenon.
The ability of control and MdfA-expressing E. coli cells to
extrude drugs against a concentration gradient was tested at a
pH range of 6.5–8.5. Transport of each of the positively charged
substrates EtBr and TPP by MdfA-expressing cells was inhib-
ited gradually by increasing the external pH, with a complete
arrest of transport at pH 8.5 (Fig. 2 A and B Left). In contrast,
transport of the uncharged chloramphenicol was affected to a
much lesser degree by the external pH, and substantial transport
of chloramphenicol was still apparent at pH 8.5 (Fig. 2C Left).
Importantly, the uptake of all the test drugs by control cells (that
do not express MdfA) is only slightly affected by identical pH
changes (Fig. 2 B Right and C Right). Therefore, it seems likely
that the pH dependence of MdfA-mediated resistance to cat-
ionic drugs (Fig. 1) is due to the inhibitory effect of a basic pH
on their transport.
The Dissipation of  or pH Has Distinct Effects on the Transport of
Differentially Charged Substrates. By gradually raising the extra-
cellular pH, the pH (inside alkaline) across the cytoplasmic
Fig. 1. Resistance of E. coli UTmdfA::kan cells toward differentially charged
drugs at various pH values. (A) Cells harboring plasmid pT7-5 (upper line, each
panel) or pT7-5 MdfA (lower line, each panel) were tested for their ability to
grow in the presence of each of several drugs at various pH values. Ten-fold
dilutions of cells were plated from right to left. The drugs tested were EtBr at
500 gml, benzalkonium chloride (Bz) at 20 gml, chloramphenicol (Cm) at
8 gml, and thiamphenicol (Tm) at 20 gml. (B) Mdr of control cells
(harboring plasmid pT7-5) was tested at the indicated pH values. Ten-fold
dilutions of cells were plated from right to left. The drugs tested were EtBr at
20gml, benzalkonium chloride at 0.8gml, chloramphenicol at 0.2gml,
and thiamphenicol at 0.3 gml.
Fig. 2. Effect of pH on transport of positively charged and neutral substrates.
(A) Efflux of EtBr (5M) by preloaded cells. EtBr fluorescence is increased after
interaction with DNA and RNA, and efflux of EtBr is represented by a decrease
in fluorescence. Trace 1, control cells lacking MdfA at pH 7.0. Traces 2–6, EtBr
efflux mediated by MdfA-expressing cells at pH 6.5, 7.0, 7.5, 8.0, and 8.5,
respectively. Glucose (0.2%) was added at 100 sec to energize the cells. CCCP
(10 M) was added after 300–500 sec to abolish the  H-driven transport.
A.U., arbitrary units. (B Left) MdfA-mediated decreased accumulation of
[3H]TPP (50 M) in energized cells. (C Left) MdfA-mediated decreased accu-
mulation of [3H]chloramphenicol (2 M) in energized cells. (B Right and C
Right) Accumulation of [3H]TPP (50 M) or [3H]chloramphenicol (2 M) by
control cells. For direct comparison, the traces representing control cells
assayed at pH 7.0 are shown also as dashed traces (B Left and C Left). Filled
squares, pH 6.5; filled triangles, pH 7.0; filled circles, pH 7.5; open squares, pH
8.0; and open triangles, pH 8.5. Error bars are indicated unless they are smaller
than the icons.








membrane is diminished progressively, reaching 0 mV at a pH
value of 7.6, whereas reversing its direction at higher pH (23).
Therefore, because both the MdfA-mediated resistance to and
transport of cationic substrates require an inwardly directed
proton gradient, we speculated that their transport is driven by
the pH. Conversely, because resistance and transport with the
uncharged drugs were shown to be less dependent on the pH and
presumably the proton gradient, we reasoned that for this group
of substrates, the transport might be driven also by the  (inside
negative). To test this hypothesis, we assayed the transport of
various drugs in the presence of ionophores that selectively
abolish either component of  H. To facilitate the accessibility
of ionophores to the cytoplasmic membrane, we used the
outer-membrane permeability mutant, E. coli UTL2 (24), and
EDTAethanol treatment. Rapid EtBr efflux from cells express-
ing MdfA was observed compared with control cells (Fig. 3A,
traces 2 and 1, respectively). However, EtBr efflux was abolished
completely by nigericin, which in the presence of potassium
selectively abolishes the pH (Fig. 3A, trace 4). In contrast, the
transport of EtBr remained unchanged or even slightly acceler-
ated in the presence of valinomycin, which under these condi-
tions selectively abolishes  (Fig. 3A, trace 3). With the control
cells, no effect of the ionophores on the slow efflux was observed
(data not shown). Similar results were obtained in transport
experiments of the cationic substrate Hoechst 33342 (19), with
inverted membrane vesicles prepared from MdfA-expressing
cells. The results show substantial Hoechst 33342 transport by
MdfA-containing vesicles compared with control vesicles (Fig.
3B, compare the first 150 sec of traces 2 and 3 with trace 1). The
MdfA-mediated transport was abolished by nigericin (Fig. 3B,
trace 2) yet was stimulated markedly by valinomycin, suggesting
a role for pH (Fig. 3B, trace 3). No effect of valinomycin was
observed in control vesicles (Fig. 3B, trace 4). Next we tested the
effects of the same ionophores on transport of the neutral
substrate chloramphenicol at pH 7.0 (Fig. 3C Left) and 6.5 (Fig.
3C Right). In both cases, cells expressing MdfA accumulated less
chloramphenicol than control cells, indicating that MdfA expels
the antibiotic. However, unlike with cationic substrates, the
transport of chloramphenicol at pH 7.0 was inhibited drastically
by valinomycin. Under these conditions (pH 7.0) nigericin
inhibited transport to a much lesser extent (Fig. 3C Left). At pH
6.5 the inhibitory capacity of both ionophores was almost
identical, and substantial transport was observed in both cases.
The effects of the ionophores on substrate accumulation by
control cells were negligible (data not shown). These results
suggest that the transport of cationic substrates is driven by pH
and not by , whereas the transport of neutral compounds
depends on both components of  H. The stimulation of the
transport of positively charged substrates by valinomycin reflects
a compensatory increase in pH after depletion of .
The Membrane Potential Is Dissipated Only by the Transport of
Electroneutral Drugs. Thus far, the results have suggested that the
MdfA-mediated transport of cationic substrates differs from that
of uncharged substrates with regard to the driving force. To
explore the electrogenicity of these presumably distinct transport
reactions, we measured the effect of the transport of various
drugs on a preestablished . Inverted membrane vesicles were
energized by the addition of ATP, and the formation of a 
(inside positive) was followed by fluorescence spectroscopy
using the -sensitive dye oxonol V. The  generated by
vesicles prepared from MdfA-expressing cells or from control
cells was indistinguishable (Fig. 4). After the  achieved a
steady-state level, various substrates were added in concentra-
tions that had no effect on the oxonol V fluorescence or on the
 generated by control vesicles (Fig. 4A, data not shown). The
addition of benzalkonium to MdfA-containing vesicles did not
dissipate the  but rather caused a small but reproducible
increase in its magnitude (Fig. 4D). A similar effect on  was
observed by the addition of nigericin (Fig. 4E). In both cases,
dissipation of the pH resulted in an increase of . However,
in contrast to the effects of benzalkonium or nigericin, adding
chloramphenicol or thiamphenicol to MdfA-containing vesicles
resulted in a marked dissipation of  (Fig. 4 B and C). Taken
together, these results suggest that the transport of cationic
substrates is electroneutral, whereas that of neutral substrates is
electrogenic.
Reconstituted MdfA Catalyzes both Electrogenic and Electroneutral
Transport. To determine whether the MdfA protein suffices to
catalyze both electrogenic and electroneutral transport, we
purified and reconstituted the transporter in proteoliposomes.
The reconstituted MdfA is functional, as demonstrated by
transport assays with chloramphenicol and TPP (Fig. 5). Trans-
port assays were driven by artificially imposed diffusion poten-
tials (see Materials and Methods). The established potentials
were evaluated routinely by using oxonol V and 9-amino-6-
chloro-2-methoxyacridine fluorescence for  and pH, respec-
tively. The uptake of chloramphenicol into proteoliposomes was
driven not only by an artificially imposed  H but also by an
imposed  (inside positive), suggesting that, by definition,
Fig. 3. Effect of dissipation of  or pH on the transport of differentially
charged substrates by MdfA. (A) Efflux of EtBr (5 M) from preloaded EDTA
ethanol-treated E. coli UTLmdfA::kan cells was measured at pH 7.0. Trace 1,
control cells lacking MdfA; trace 2, MdfA-expressing cells; trace 3, MdfA-
expressing cells in the presence of 5M valinomycin; trace 4, MdfA-expressing
cells in the presence of 2 M nigericin. Glucose (0.2%) was added at 80 sec to
energize the cells. CCCP (C*) (10 M) was added, as indicated by the arrows,
to abolish  H-driven transport. A.U., arbitrary units. (B) Transport of
Hoechst 33342 in inverted membrane vesicles prepared from cells overexpress-
ing MdfA or control cells at pH 7.0. Transport was initiated by the addition of
0.2 mM ATP as indicated. Trace 1, control vesicles [nigericin (2 M) was added
as indicated by an arrow]; trace 2, MdfA-containing vesicles [nigericin (2 M)
was added as indicated by an arrow]; trace 3, MdfA vesicles [valinomycin
(2 M) was added as indicated by an arrow]; trace 4, control vesicles [valino-
mycin (2 M) was added as indicated by an arrow]. (C) Accumulation of
[3H]chloramphenicol (2 M) by EDTAethanol-treated E. coli UTLmdfA::kan
cells at pH 7.0 (Left) and 6.5 (Right). Open circles, control cells; filled circles,
MdfA-expressing cells; filled triangles, MdfA-expressing cells in the presence
of 5 M valinomycin; filled squares, MdfA-expressing cells in the presence of
2 M nigericin. Error bars are indicated unless they are smaller than the icons.
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transport is electrogenic. As expected, pH alone (inside acid)
also drove chloramphenicol uptake by MdfA-containing lipo-
somes (Fig. 5A). With the positively charged substrate TPP, the
 H-driven transport was similar to that observed when only a
pH (inside acid) was imposed. However, generating only a 
(inside positive) failed to drive TPP transport into the proteo-
liposomes (Fig. 5B). These results indicate that unlike with the
neutral substrate chloramphenicol, the  is not sufficient for
the active transport of TPP, whereas p suffices for the
uptake. Therefore, MdfA catalyzes both the electrogenic and
electroneutral transport reactions without the need for accessory
components.
Discussion
Most secondary transporters are specific regarding their sub-
strate recognition properties and transport driving forces. In
contrast, Mdr transporters are remarkably promiscuous in var-
ious basic aspects of active transport. Unlike the former trans-
porters that specialize in the transport of a well-defined set of
molecules, Mdr transporters are able to extrude a large number
of chemically dissimilar compounds. In addition to being dis-
similar in their chemical structure, the substrates of many Mdr
transporters also differ in their charge. Moreover, as demon-
strated here with MdfA, the remarkable versatility of these
transporters is exemplified further by their ability to catalyze
dissimilar transport reactions.
Theoretically, in extruding a positively charged compound
across the cell membrane, the transporter must move the charges
against the transmembrane electrical potential,  (inside neg-
ative), unlike with uncharged compounds. Accordingly, the
transport of uncharged compounds seems more energetically
favorable than the transport of charged substrates. Nevertheless,
lipophilic cations clearly make up the majority among the
substrates of MdfA. From a bioenergetic standpoint, a trans-
porter that has to deal with differentially charged substrates has
at least three theoretical modes of action: (i) the transporter may
use different drugproton stoichiometries with neutral versus
positively charged, thus balancing the charge difference between
the substrates with the appropriate number of counter ions;
(ii) the transporter may cotransport an additional charged
molecule with some of its substrates to reach the same net charge
movement in each of the transport reactions; and (iii) the
transporter may use an equal drugproton stoichiometry with all
the substrates, and because the charge of the substrates differs,
this must result in different electrogenicities of the different
transport reactions. Here we investigated this issue by using
MdfA as a model Mdr transporter. The results clearly demon-
strate the existence of two types of transport reactions that differ
in their electrogenicity. With the monovalent cationic substrates,
because their transport is electroneutral, we suggest a proton
substrate stoichiometry of 1 for these substrates. Also for the
electroneutral substrates, because their transport is electrogenic,
we suggest a protonsubstrate stoichiometry of 1, although
higher values cannot be ruled out at this stage.
Initial indications of dissimilar transport reactions could al-
ready be deduced from experiments examining the in vivo
Fig. 4. Changes in the transmembrane electrical potential (inside positive)
after additions of differentially charged substrates. Membrane vesicles were
energized by the addition of 0.4 mM ATP, and the consequent membrane
potential was monitored by oxonol V (0.5 M) fluorescence. CCCP (C*, 5 M)
was added to completely abolish the membrane potential. The upper-most
trace represents control vesicles, and all other traces represent MdfA-
containing vesicles. Substrates were added where indicated at the following
concentrations: 15 M chloramphenicol (Cm), 15 M thiamphenicol (Tm), 2
M benzalkonium chloride (Bz), and 0.2 M nigericin (Nig). Vec, vector, no
MdfA.
Fig. 5. Uptake of [3H]chloramphenicol or [3H]TPP into MdfA proteolipo-
somes. (A) Uptake of 2 M [3H]chloramphenicol: 2 l of proteoliposomes
(1.5g of protein perl) were diluted 100-fold into the appropriate buffer (as
detailed in Materials and Methods) to impose the indicated diffusion poten-
tials. (B) Uptake of 1 M [3H]TPP: 0.5 l of proteoliposomes (8 g of protein
per l) were diluted 100-fold into the appropriate buffer (as detailed in
Materials and Methods) to impose the indicated diffusion potentials. Net
values are shown, after subtraction of the amount of substrate accumulated
in liposomes devoid of MdfA, under identical conditions. Error bars are
indicated.








function of MdfA as an Mdr protein. By increasing the external
pH, the resistance of cells expressing MdfA to cationic drugs was
hampered, yet resistance to uncharged drugs remained unaf-
fected (Fig. 1). The differential effect of pH was shown to be
specific for MdfA-expressing cells. Direct evidence for a strong
correlation between the export of positively charged drugs and
the pH (inside alkaline) came from transport assays with whole
cells. In contrast, the transport of an uncharged drug proved to
depend less on the pH (Fig. 2), probably because of the MdfA
ability to use also as a driving force for transport of uncharged
drugs. Similar conclusions were derived from transport experi-
ments of differentially charged substrates in the presence of
valinomycin or nigericin (Fig. 3), which strongly indicated that
the transport of positively charged substrates depends solely on
a pH and completely independent of the . In contrast, the
transport of uncharged substrates proved to depend on both
components of the  H. The experiments described in Fig. 3C
clearly demonstrate the versatile ability of MdfA in using either
component of  H for transport of an uncharged substrate. At
pH 7.0,  constitutes 70% of the proton motive force,
whereas pH constitutes 30% (23). Accordingly, the addition
of valinomycin abolishes a major part of the MdfA-mediated
chloramphenicol transport, whereas addition of nigericin exerts
a minor effect (Fig. 3C Left). At pH 6.5, the contribution of 
and pH to the overall driving force is approximately equal (23),
as also reflected by the inhibitory effect of the ionophores on
chloramphenicol transport (Fig. 3C Right). Transport experi-
ments with reconstituted MdfA (Fig. 5) suggested that its ability
to perform dissimilar transport reactions is independent of
accessory components and is an inherent property of the trans-
porter. This phenomenon was established further in inverted
membrane vesicles and preformed  (inside positive). The
addition of electroneutral drugs consumed the , whereas the
transport of positively charged drugs led to an increase in
the magnitude of the  (Fig. 4). Taking into account that  H
is a relatively constant value, the consumption of pH through
the electroneutral exchange of a positively charged drug and a
proton will bring about a concomitant increase in . A similar
effect on  was exerted by nigericin, which operates as an
electroneutral HK exchanger, hence converting pH to 
(Fig. 4).
Because for secondary transport systems described to date
transport has been characterized as being either electrogenic
or electroneutral, MdfA provides an example of a secondary
transporter able to catalyze both types of transport. These re-
sults do not only offer an explanation for a basic phenomenon,
how Mdr transporters deal with substrates differing in their
charge, but also raise clinically oriented considerations in the
treatment of multidrug-resistant bacterial strains; e.g., the use of
certain positively charged drugs may be advantageous in a basic
environment.
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